Microfluidic lung cancer models: Bridging clinical treatment strategies and tumor microenvironment recapitulation.

Yu Z, Khan AA, Naeem W, Borgia JA, Liptay MJ, Seder CW, Zhou J

Open source

DOI
10.1063/5.0282002
Published
2025 Dec
Container
APL bioengineering
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1063/5.0282002,
  title = {Microfluidic lung cancer models: Bridging clinical treatment strategies and tumor microenvironment recapitulation.},
  author = {Yu Z and Khan AA and Naeem W and Borgia JA and Liptay MJ and Seder CW and Zhou J},
  year = {2025},
  journal = {APL bioengineering},
  doi = {10.1063/5.0282002},
  url = {https://doi.org/10.1063/5.0282002}
}

RIS

TY  - JOUR
TI  - Microfluidic lung cancer models: Bridging clinical treatment strategies and tumor microenvironment recapitulation.
AU  - Yu Z
AU  - Khan AA
AU  - Naeem W
AU  - Borgia JA
AU  - Liptay MJ
AU  - Seder CW
AU  - Zhou J
PY  - 2025
JO  - APL bioengineering
DO  - 10.1063/5.0282002
UR  - https://doi.org/10.1063/5.0282002
ER  - 

APA

Z, Y., AA, K., W, N., JA, B., MJ, L., CW, S., & J, Z. (2025). Microfluidic lung cancer models: Bridging clinical treatment strategies and tumor microenvironment recapitulation.. APL bioengineering. https://doi.org/10.1063/5.0282002

Source records